pharma

3 min read

• Business News

Stocks to Watch: Aurobindo, Sun Pharma, Future Retail, Vedanta, Voda Idea

February 28, 2022 Diana B. Mock

&#13 &#13 &#13 The vital benchmark indices are very likely to start trade on...

3 min read

• Business News

Stocks to Watch: Aurobindo, Sun Pharma, Future Retail, Vedanta, Voda Idea

February 28, 2022 Diana B. Mock

&#13 &#13 &#13 The vital benchmark indices are very likely to start trade on...

2 min read

• Wealth Management Firms

Destiny Pharma PLC unveils further positive results for c-difficile treatment as market research points to its commercial potential

January 25, 2022 Diana B. Mock

NTCD-M3, which researchers are readying to stage III scientific trials, was the subject to...

2 min read

• Wealth Management Firms

Destiny Pharma PLC unveils further positive results for c-difficile treatment as market research points to its commercial potential

January 25, 2022 Diana B. Mock

NTCD-M3, which researchers are readying to stage III scientific trials, was the subject to...

1 min read

• Finance Advisor

Destiny Pharma – Neil Clark, CEO (AIM:DEST) One2One Virtual Forum 10th December 2021

December 15, 2021 Diana B. Mock

Future Pharma PLC (Aim:DEST) (Future Pharma PLC (Aim:DEST)) is a medical phase, impressive biotechnology...

2 min read

• Wealth Management Firms

Pharma CFO Charged With Insider Trading

December 8, 2021 Diana B. Mock

Previous Immunomedics CFO Usama Malik and his ex-girlfriend have been billed with employing inside...

2 min read

• Wealth Management Companies

Destiny Pharma PLC looks to build on the progress made with its two key assets

September 16, 2021 Diana B. Mock

The corporation is blazing a trail in the infection arena and reckons it has...

1 min read

• Wealth Management Companies

Destiny Pharma PLC teams up with US Department of Veterans Affairs to find ‘new attributes’ for its next-generation antibiotic

July 10, 2021 Diana B. Mock

NTCD-M3 is staying made to beat Clostridioides difficile infections (CDI) in the gut ()...

2 min read

• Business Advice

Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment

June 12, 2021 Diana B. Mock

CEO Neil Clark reported: “We have made major development given that closing the £10.4mln...

2 min read

• Business Advice

Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment

June 12, 2021 Diana B. Mock

CEO Neil Clark reported: “We have made major development given that closing the £10.4mln...